Wasatch Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.54M Sell
233,604
-20,327
-8% -$572K 0.04% 164
2026
Q1
$7.24M Sell
253,931
-99,946
-28% -$3.41M 0.05% 143
2025
Q4
$14M Sell
353,877
-54,878
-13% -$2.01M 0.08% 137
2025
Q3
$14.4M Sell
408,755
-98,067
-19% -$3.38M 0.08% 140
2025
Q2
$16.6M Buy
506,822
+15,250
+3% +$496K 0.09% 134
2025
Q1
$15.9M Sell
491,572
-115,792
-19% -$4.3M 0.09% 136
2024
Q4
$18.6M Sell
607,364
-161,888
-21% -$5.21M 0.09% 137
2024
Q3
$21.6M Sell
769,252
-20,562
-3% -$507K 0.11% 129
2024
Q2
$18M Buy
789,814
+69,137
+10% +$1.6M 0.1% 128
2024
Q1
$21.9M Buy
720,677
+200,799
+39% +$6.73M 0.11% 130
2023
Q4
$18.6M Sell
519,878
-43,410
-8% -$1.61M 0.1% 132
2023
Q3
$24.7M Sell
563,288
-44,844
-7% -$2.19M 0.16% 117
2023
Q2
$30M Buy
608,132
+196
+0% +$9.03K 0.18% 101
2023
Q1
$25.2M Buy
607,936
+173,354
+40% +$7.19M 0.16% 116
2022
Q4
$19.3M Sell
434,582
-4,443
-1% -$186K 0.13% 137
2022
Q3
$17.2M Buy
439,025
+145,195
+49% +$6.64M 0.12% 147
2022
Q2
$12M Sell
293,830
-4,718
-2% -$223K 0.08% 162
2022
Q1
$19.6M Buy
298,548
+76,765
+35% +$4.97M 0.1% 156
2021
Q4
$15.4M Sell
221,783
-356
-0.2% -$25.9K 0.06% 176
2021
Q3
$15.4M Buy
222,139
+1,709
+0.8% +$132K 0.06% 185
2021
Q2
$17.5M Sell
220,430
-255,222
-54% -$18.6M 0.07% 191
2021
Q1
$31.2M Sell
475,652
-65,893
-12% -$4.06M 0.14% 131
2020
Q4
$30.1M Sell
541,545
-381,437
-41% -$16.5M 0.15% 119
2020
Q3
$36.8M Buy
922,982
+115,395
+14% +$4.89M 0.23% 103
2020
Q2
$36.3M Buy
807,587
+58,736
+8% +$2.56M 0.26% 97
2020
Q1
$25.2M Buy
748,851
+66,298
+10% +$2.38M 0.26% 86
2019
Q4
$22.2M Sell
682,553
-5,294
-0.8% -$151K 0.18% 105
2019
Q3
$17.2M Buy
687,847
+16,011
+2% +$457K 0.16% 109
2019
Q2
$20M Buy
671,836
+106,475
+19% +$3.11M 0.2% 103
2019
Q1
$15.1M Buy
565,361
+166,578
+42% +$5.06M 0.17% 99
2018
Q4
$12.2M Sell
398,783
-1,006
-0.3% -$31.3K 0.16% 99
2018
Q3
$14M Buy
399,789
+32,050
+9% +$1.01M 0.16% 96
2018
Q2
$9.95M Sell
367,739
-19,051
-5% -$448K 0.12% 116
2018
Q1
$7.94M Sell
386,790
-35,214
-8% -$636K 0.1% 127
2017
Q4
$7.7M Sell
422,004
-1,959
-0.5% -$38.8K 0.1% 134
2017
Q3
$9.48M Sell
423,963
-13,341
-3% -$302K 0.13% 117
2017
Q2
$10.6M Sell
437,304
-25,940
-6% -$551K 0.15% 110
2017
Q1
$8.87M Sell
463,244
-12,055
-3% -$211K 0.13% 124
2016
Q4
$9.3M Sell
475,299
-28,000
-6% -$507K 0.14% 122
2016
Q3
$7.96M Buy
503,299
+28,762
+6% +$442K 0.12% 146
2016
Q2
$6.71M Buy
474,537
+57,610
+14% +$878K 0.1% 170
2016
Q1
$7.06M Sell
416,927
-9,689
-2% -$170K 0.11% 165
2015
Q4
$9.57M Buy
426,616
+19
+0% +$392 0.13% 158
2015
Q3
$9.35M Sell
426,597
-95,907
-18% -$2.4M 0.12% 171
2015
Q2
$12.9M Sell
522,504
-93,383
-15% -$2.09M 0.14% 167
2015
Q1
$12.6M Sell
615,887
-11
-0% -$213 0.13% 156
2014
Q4
$12.3M Sell
615,898
-22,405
-4% -$384K 0.13% 160
2014
Q3
$9.4M Sell
638,303
-6,637
-1% -$106K 0.1% 194
2014
Q2
$11.9M Buy
644,940
+5,665
+0.9% +$94.3K 0.12% 189
2014
Q1
$12M Sell
639,275
-196,349
-23% -$4.02M 0.12% 188
2013
Q4
$15.6M Sell
835,624
-46,246
-5% -$672K 0.15% 163
2013
Q3
$9.68M Buy
881,870
+27,771
+3% +$274K 0.1% 197
2013
Q2
$8.11M Buy
+854,099
New +$7.44M 0.09% 213

Other funds holding ATRC

Wasatch Advisors's ATRC Position: Q2 2026 in Review

Wasatch Advisors reduced its AtriCure (ATRC) stake by 8% in Q2 2026, selling an estimated $572K and leaving 233,604 shares worth $6.54M. The position accounts for 0.04% of the portfolio, ranked #164.

Wasatch Advisors first reported a position in ATRC in Q2 2013 and has held it in 53 quarters since. The position peaked at $36.8M in Q3 2020. 15 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Wasatch Advisors held 233,604 shares of AtriCure worth $6.54M as of Q2 2026.
  • Wasatch Advisors sold 20,327 AtriCure shares in Q2 2026, an estimated $572K.
  • AtriCure made up 0.04% of Wasatch Advisors's portfolio in Q2 2026, its #164 holding.
  • Wasatch Advisors first reported a position in AtriCure in Q2 2013 and has held it in 53 quarters since.
  • Wasatch Advisors's AtriCure position peaked at $36.8M in Q3 2020.
  • 15 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.